PhRMA Receives Praise from AMSA
Praise for a policy is not the normal type of thing that would be written about on this website, but since it is the American…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Prescription Project Conference: Drug Free Zones
Finally, the White House and the U. S.Capitol Building have become “drug-free” zones from the corrosive and corrupting influence…
New York Times Editorial: Completely Sever Financial Ties to Industry
If you ever wondered what the editors of The New York Times (hereinafter, The Times) really think about manufacturer-funded…
Letters From Grassley: Harvard and Biederman Get the Facts
Joseph Biederman, M,D,, the renowned Harvard Child Psychiatrist at Massachusetts General Hospital (Mass. General), has agreed to…
The Dark Angell
Recently Marcia Angell, M.D., the significant other of Arnold S. Relman, M.D., both former Editors of The New England Journal of…
Health Care Reform: McKinsey Report – Where is all the Money Going
There is great debate around the causes of why healthcare is so expensive and why the cost increases every year regardless of…
AdvaMed Releases Revised Code of Conduct
In an effort to track PhRMA and reduce conflicts of interest AdvaMed released a major update of its Code of Ethics on…
Letters from Grassley: Emory Surrenders
“Emory’s swift and sure-footed response sets an example for other research institutions to follow and for the National Institutes…
Physician Payment Sunshine Act: CBO – Building Block to Further…
The reporting system that this option would implement, and the data that would be collected as a result, could become a…
Letters from Grassley: Emory — Release the Hounds
I want to ensure that Emory and/or Dr. Nemeroff are fully aware of the penalties for making false statements and/or obstructing…